Recurrent oropharyngeal candidiasis with Candida albicans and Candida dubliniensis in an HIV-infected patient: Mycology, genotyping and immunology characteristics;Candidose oropharyngée récidivante à Candida albicans et ̀a Candida dubliniensis chez une patiente infectée par le VIH: Aspects mycologiques, génotypiques et immunologiques

Journal de Mycologie Medicale

Volumn 11, Issue 3, 2001, Pages 153-158

  Millon, L ^a   Piarroux, R ^a   Drobacheff, C ^a   Monod, M ^a   Bulle, B ^a   Bole, J ^a   Reboux, G ^a   Meillet, D ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Candida dubliniensis; Genotyping; HIV; Humoral mucosal response; Oropharyngeal candidiasis; Secreted aspartyl protease

Indexed keywords

ANTIRETROVIRUS AGENT; ASPARTIC PROTEINASE; DIDANOSINE; FLUCONAZOLE; FUNGAL DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RITONAVIR; STAVUDINE;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; FUNGAL GENETICS; FUNGUS IDENTIFICATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; KARYOTYPE; NUCLEOTIDE SEQUENCE; PHARYNGITIS; PHENOTYPE; RECURRENT INFECTION; TREATMENT OUTCOME;

EID: 0035211666     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Quantitative cultures of Candida from mouthwash fluid in HIV-infected patients: A longitudinal study
2. Cluster of atypical Candida isolates in a group of human immunodeficiency virus-positive drug users
3. Candida dubliniensis fungemia: The first four cases in North America
4. Role of protease inhibitors in preventing recurrent oral candidosis in patient with HIV-infection: A prospective case-control study
5. Molecular and phenotypic analysis of Candida dubliniensis: A recently identified species linked with oral candidosis in HIV-infected and AIDS patients
6. Candida dubliniensis: Phylogeny and putative virulence factors
7. Association of plasma levels of human immunodeficiency virus type 1 RNA and oropharyngeal Candida colonization
8. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors
9. Candida albicans secreted aspartyl proteinases
10. In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus
11. Host factors associated with HIV-related oral candidiasis
12. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea
13. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus
14. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation
15. Longitudinal study of anti-Candida albicans mucosal immunity against aspartic proteinase in HIV-infected patients
16. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: Persistence of Candida albicans strains with the same genotype
17. Antifungal drug susceptibility of oral Candida dubliniensis isolates from HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro
18. Prevalence of Candida dubliniensis isolates in a yeast stock collection
19. Atypical strains of Candida albicans recovered from AIDS patients
20. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit
21. In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients
22. Genetic similarity and maintenance of Candida albicans stains from a group of AIDS patients, demonstrated by DNA fingerprinting
23. Cross-sectional study of oral Candida carriage in a human immunodeficiency virus (HIV)-seropositive population: Predisposing factors, epidemiology and antifungal susceptibility
24. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients
25. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients
26. Candida dabliniensis: Characteristics and identification
27. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals
28. Resolution of azole-resistant oropharygeal candidiasis after initiation of potent combination antiretroviral therapy
29. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA